SCHEMBL128616

SCHEMBL128616

CCc1cc(N(CCCO)CCCO)ccc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 2/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
BCL2L1 Q07817 1/20 0.39
MCL1 Q07820 1/20 0.39
SLC16A3 O15427 3/20 0.38
SLC16A1 P53985 3/20 0.38
HPGD P15428 2/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RECQL P46063 1/20 0.38
PTPN11 Q06124 1/20 0.37
PTPRO Q16827 1/20 0.37
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7506757 0.83 ALDH1A1 (0.45) ALDH1A1KDM4EPOLBGAAMEN1
SCHEMBL1814072 0.82 MEN1 (0.57) ALDH1A1KDM4EPOLBGAAMEN1
SCHEMBL9249843 0.78 SLC16A3 (0.40) ALDH1A1KDM4EPOLBGAAMEN1
SCHEMBL7601521 0.77 SLC16A3 (0.46) ALDH1A1KDM4EPOLBGAAMEN1
SCHEMBL7877999 0.77 GABRP (0.42) ALDH1A1KDM4EPOLBGAAMEN1
SCHEMBL41899 0.77 SLC16A3 (0.46) ALDH1A1KDM4EPOLBGAAMEN1
SCHEMBL7586557 0.76 KMT2A (0.42) ALDH1A1KDM4EPOLBGAAMEN1
Monoethanolamine SCHEMBL9339507 0.76 SLC16A3 (0.40) ALDH1A1KDM4EPOLBMEN1KMT2A
SCHEMBL27525031 0.76 KDM4E (0.50) ALDH1A1KDM4EPOLBGAASLC16A3
Ammonia Solution, Strong SCHEMBL4440047 0.76 SLC16A3 (0.45) ALDH1A1KDM4EPOLBGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3600224-B1 SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2026-05-06 EP claimed
EP-4061326-B1 PERSONAL CARE COMPOSITION COMPRISING A MULTISTAGE POLYMER DOW GLOBAL TECHNOLOGIES LLC (US) 2026-02-25 EP claimed
EP-4093514-B1 AQUEOUS SUNCASE FORMULATION BASED ON SULFATED A CRYSTALLINE CELLULOSE SPF BOOSTER DOW GLOBAL TECHNOLOGIES LLC (US) 2025-08-06 EP claimed
US-12214067-B2 Oil-in-water emulsion sunscreen composition ISP INVESTMENTS INC. (US) 2025-02-04 US claimed
EP-3894017-B1 POLYMER BLEND FOR PERSONAL CARE FORMULATION DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-28 EP claimed
EP-3893836-B1 PERSONAL CARE FORMULATION COMPRISING A MULTISTAGE POLYMER WITH A CARBOSILOXANE DOW GLOBAL TECHNOLOGIES LLC (US) 2022-12-28 EP claimed
US-20220387290-A1 SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-12-08 US claimed
US-20220125701-A1 SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-04-28 US claimed
US-20210338539-A1 LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC 2021-11-04 US claimed
US-11110049-B2 Composition and method for improving the appearance of skin THE PROCTER & GAMBLE COMPANY (US) 2021-09-07 US claimed
EP-1608331-B1 SUNSCREEN COMPOSITION COMPRISING A MIXTURE OF SILICAS JOHNSON & JOHNSON IND LTDA (BR) 2007-11-07 EP claimed
WO-2007084721-A2 SKIN PROTECTION AND MOISTURIZING COMPOSITIONS AND METHODS SAKURA PROPERTIES, LLC (US) 2007-07-26 WO claimed
EP-1092421-B1 Method for preparing ultraviolet radiation absorbing compositions ROHM & HAAS (US) 2007-03-21 EP claimed
US-20060210496-A1 COMPOSITIONS FOR SKIN PROTECTION FROM ULTRAVIOLET DAMAGE SAKURA PROPERTIES, LLC 2006-09-21 US claimed
EP-1173146-B1 LIQUID SUNSCREEN COMPOSITIONS WHICH BOTH DEPOSIT AND LATHER WELL UNILEVER PLC (GB) 2002-11-20 EP claimed
US-6399045-B1 MINIMUM CATIONIC POLYMER WITH SUNSCREEN AGENT AT LEVEL BEYOND ITS SOLUBILITY LIMIT IN SURFACTANT; ENHANCED SPF; OPAQUE UNILEVER HOME & PERSONAL CARE USA A DIVISION OF CONOPCO, INC. 2002-06-04 US claimed
EP-1173146-A1 LIQUID SUNSCREEN COMPOSITIONS WHICH BOTH DEPOSIT AND LATHER WELL UNILEVER PLC (GB) 2002-01-23 EP claimed
EP-0761201-B1 Ultraviolet radiation absorption composition ROHM & HAAS (US) 2002-01-09 EP claimed
US-6224852-B1 WITH MIXTURES OF SURFACTANTS CONTAINING AT LEAST ONE ANIONIC SURFACTANT, CATIONIC POLYMER AND SUNSCREEN AGENT UNILEVER HOME & PERSONAL CARE USA 2001-05-01 US claimed
WO-2000064406-A1 LIQUID SUNSCREEN COMPOSITIONS WHICH BOTH DEPOSIT AND LATHER WELL UNILEVER PLC (GB) 2000-11-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060210496-A1 COMPOSITIONS FOR SKIN PROTECTION FROM ULTRAVIOLET DAMAGE FUCA1, XRCC6, XRCC5 ALDH1A1 1322/4885KDM4E 2947/4885POLB 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.